March 21, 2007—Tyco Healthcare Inc, St. Louis, Mo, announced today that Timothy R. Wright has been appointed president of the company’s Pharmaceutical Products and Imaging Solutions business segments. Tyco’s Pharmaceutical Products business is worth $1.2 billion, its Imaging Solutions business $900 million.

“Tim is a health care industry veteran whose broad global experience makes him an ideal leader of these two rapidly growing businesses,” said Richard J. Meelia, Tyco CEO. “We’re confident that Tim’s strong focus on patients, extensive track record of accomplishment and wealth of industry knowledge will enable our pharmaceutical and imaging businesses to execute with excellence on both current and long-term strategies.”

Before joining Tyco, Wright was the interim CEO and a member of the board of directors of AAIPharma; he also previously held executive positions with Xanodyne Pharmaceuticals and Elan Bio-Pharmaceuticals.

“Our Pharmaceutical Products and Imaging Solutions business segments have long-standing vertically integrated development and manufacturing capabilities that are world-class,” Wright said. “And more importantly, we have a unique understanding and expertise in the development, manufacturing, and commercialization of controlled substances, nuclear medicine and imaging agents.”

—Cat Vasko